PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10612569-1	1999	OBJECTIVE: We previously observed increased expression of interleukin-1beta, platelet-derived growth factor-A, and insulin-like growth factor-I in bronchoalveolar lavage (BAL) cells during the development of pulmonary fibrosis after an intraperitoneal administration of bleomycin in mice.	Bleomycin	270-279	insulin-like growth factor 1	Mus musculus	94-143	
8617091-0	1996	Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice.	Bleomycin	129-138	insulin-like growth factor 1	Mus musculus	61-89	
32269725-0	2020	Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.	Bleomycin	22-31	insulin-like growth factor 1	Mus musculus	82-87	
32269725-7	2020	Our study showed that intratracheal injection of bleomycin induced pulmonary fibrosis in mice, with observed elevation in collagen, fibronectin and alpha-SMA level, characterized by the enhanced IGF-1 and PI3K expression.	Bleomycin	49-58	insulin-like growth factor 1	Mus musculus	195-200	
32269725-9	2020	Our results show that metformin attenuates bleomycin-induced pulmonary fibrosis via IGF-1 pathway.	Bleomycin	43-52	insulin-like growth factor 1	Mus musculus	84-89	
23987664-8	2013	The relevance of the IGF-1 pathway in this model was then demonstrated by showing lung tissue of bleomycin treated C57BL/6J mice had increased expression of Igf1 and that increased numbers of Igf-1 positive cells, predominantly in macrophages, were detected in the lungs.	Bleomycin	97-106	insulin-like growth factor 1	Mus musculus	21-26	
30121056-0	2018	Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma Background/aim: Insulin-like growth factor (IGF)-I is a differentiation and growth factor.	Bleomycin	42-51	insulin-like growth factor 1	Mus musculus	88-122	
23987664-8	2013	The relevance of the IGF-1 pathway in this model was then demonstrated by showing lung tissue of bleomycin treated C57BL/6J mice had increased expression of Igf1 and that increased numbers of Igf-1 positive cells, predominantly in macrophages, were detected in the lungs.	Bleomycin	97-106	insulin-like growth factor 1	Mus musculus	157-161	
23987664-8	2013	The relevance of the IGF-1 pathway in this model was then demonstrated by showing lung tissue of bleomycin treated C57BL/6J mice had increased expression of Igf1 and that increased numbers of Igf-1 positive cells, predominantly in macrophages, were detected in the lungs.	Bleomycin	97-106	insulin-like growth factor 1	Mus musculus	192-197	
22493012-2	2012	We previously demonstrated that treatment of mice with IGF-1 receptor-blocking antibody (A12) improved early survival in bleomycin-induced lung injury.	Bleomycin	121-130	insulin-like growth factor 1	Mus musculus	55-60